These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3541623)

  • 21. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women.
    Hassager C; Christiansen C
    Metabolism; 1989 Jul; 38(7):662-5. PubMed ID: 2661966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.
    Crook D; Cust MP; Gangar KF; Worthington M; Hillard TC; Stevenson JC; Whitehead MI; Wynn V
    Am J Obstet Gynecol; 1992 Mar; 166(3):950-5. PubMed ID: 1550171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
    De Lignieres B; Basdevant A; Thomas G; Thalabard JC; Mercier-Bodard C; Conard J; Guyene TT; Mairon N; Corvol P; Guy-Grand B
    J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid metabolic studies in oophorectomized women: effects induced by two different estrogens on serum lipids and lipoproteins.
    Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
    Gynecol Obstet Invest; 1980; 11(3):161-9. PubMed ID: 7439809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of deprivation and replacement by percutaneous 17 beta estradiol and oral progesterone on blood pressure and metabolic parameters in menopause patients with non-insulin-dependent diabetes].
    Mosnier-Pudar H; Faguer B; Guyenne TT; Tchobroutsky G
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1111-5. PubMed ID: 1953259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose and duration effects of estradiol valerate on serum and lipoprotein lipids.
    Enk L; Crona N; Samsioe G; Silfverstolpe G
    Horm Metab Res; 1986 Aug; 18(8):551-4. PubMed ID: 3530933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins.
    Marsh MS; Crook D; Whitcroft SI; Worthington M; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Jan; 83(1):19-23. PubMed ID: 8272301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
    Munk-Jensen N; Ulrich LG; Obel EB; Nielsen SP; Edwards D; Meinertz H
    Am J Obstet Gynecol; 1994 Jul; 171(1):132-8. PubMed ID: 8030688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in lipids and lipoproteins with long-term estrogen deficiency and hormone replacement therapy.
    Gambrell RD; Teran AZ
    Am J Obstet Gynecol; 1991 Aug; 165(2):307-15; discussion 315-7. PubMed ID: 1872331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E; Mälkönen M; Manninen V
    N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Estrogen therapy in menopause. Clinical study in evolution (KEEPS) to explain the risk-benefit dispute to administration].
    Zárate A; Hernández-Valencia M
    Ginecol Obstet Mex; 2010 Mar; 78(3):191-4. PubMed ID: 20939224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One year follow-up of hormone replacement therapy with percutaneous estradiol and low-dose vaginal natural progesterone in women with mild to moderate hypertension.
    Spritzer PM; Vitola D; Vilodre LC; Wender MC; Reis FM; Ruschel S; Castro I
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):267-73. PubMed ID: 12951632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M; van der Mooren MJ; Mijatovic V; Bouman AA; Schijf CP; Kroeks MV; Franke HR; Kenemans P
    Menopause; 2003; 10(6):550-8. PubMed ID: 14627865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum lipoprotein changes in climacteric women induced by sequential therapy with natural estrogens and medroxy-progesterone acetate or norgestrel.
    Vejtorp M; Christensen MS; Vejtorp L; Larsen JF
    Acta Obstet Gynecol Scand; 1986; 65(5):391-5. PubMed ID: 3535357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic lipase activity during oral and parenteral 17 beta-estradiol replacement therapy: high-density lipoprotein increase may not be antiatherogenic.
    Basdevant A; de Lignieres B; Simon P; Blache D; Ponsin G; Guy-Grand B
    Fertil Steril; 1991 Jun; 55(6):1112-7. PubMed ID: 1903730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O; Lim P; Caubel P
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy.
    Kurdoglu M; Yildirim M; Kurdoglu Z; Erdem A; Erdem M; Bilgihan A; Goktas B
    Gynecol Endocrinol; 2011 Aug; 27(8):551-7. PubMed ID: 20670096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
    Gordon JL; Rubinow DR; Eisenlohr-Moul TA; Xia K; Schmidt PJ; Girdler SS
    JAMA Psychiatry; 2018 Feb; 75(2):149-157. PubMed ID: 29322164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.